Follow
Kawaljit Kaur
Kawaljit Kaur
Project scientist, UCLA
Verified email at g.ucla.edu
Title
Cited by
Cited by
Year
Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation
HC Tseng, K Kanayama, K Kaur, SH Park, S Park, A Kozlowska, S Sun, ...
Oncotarget 6 (24), 20002, 2015
1002015
Augmented IFN-γ and TNF-α induced by probiotic bacteria in NK cells mediate differentiation of stem-like tumors leading to inhibition of tumor growth and reduction in …
VT Bui, HC Tseng, A Kozlowska, PO Maung, K Kaur, P Topchyan, ...
Frontiers in immunology 6, 166180, 2015
922015
Novel strategy to expand super-charged NK cells with significant potential to lyse and differentiate cancer stem cells: differences in NK expansion and function between healthy …
K Kaur, J Cook, SH Park, P Topchyan, A Kozlowska, N Ohanian, C Fang, ...
Frontiers in immunology 8, 297, 2017
732017
Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
AK Kozlowska, P Topchyan, K Kaur, HC Tseng, A Teruel, T Hiraga, ...
Journal of Cancer 8 (4), 537, 2017
722017
Natural killer cells: diverse functions in tumor immunity and defects in pre-neoplastic and neoplastic stages of tumorigenesis
A Jewett, J Kos, K Kaur, T Safaei, C Sutanto, W Chen, P Wong, ...
Molecular Therapy-Oncolytics 16, 41-52, 2020
682020
NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis
A Jewett, J Kos, Y Fong, MW Ko, T Safaei, MP Nanut, K Kaur
Seminars in cancer biology 53, 178-188, 2018
682018
Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation …
K Kaur, P Topchyan, AK Kozlowska, N Ohanian, J Chiang, PO Maung, ...
Oncoimmunology 7 (5), e1426518, 2018
682018
Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human …
AK Kozlowska, HC Tseng, K Kaur, P Topchyan, A Inagaki, VT Bui, ...
Cancer Immunology, Immunotherapy 65, 1085-1097, 2016
652016
Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
K Kaur, MP Nanut, MW Ko, T Safaie, J Kos, A Jewett
Current opinion in immunology 51, 170-180, 2018
622018
Osteonecrosis of the jaw developed in mice: Disease variants regulated by γδ T cells in oral mucosal barrier immunity
S Park, K Kanayama, K Kaur, HCH Tseng, S Banankhah, DT Quje, ...
Journal of Biological Chemistry 290 (28), 17349-17366, 2015
542015
Probiotic-treated super-charged NK cells efficiently clear poorly differentiated pancreatic tumors in Hu-BLT mice
K Kaur, AK Kozlowska, P Topchyan, MW Ko, N Ohanian, J Chiang, ...
Cancers 12 (1), 63, 2019
492019
Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice
AK Kozlowska, K Kaur, P Topchyan, A Jewett
Cancer Immunology, Immunotherapy 65, 835-845, 2016
412016
Deficiencies in natural killer cell numbers, expansion, and function at the pre-neoplastic stage of pancreatic cancer by KRAS mutation in the pancreas of obese mice
K Kaur, HH Chang, P Topchyan, JM Cook, A Barkhordarian, G Eibl, ...
Frontiers in immunology 9, 365504, 2018
382018
Novel strategies to target cancer stem cells by NK cells; studies in humanized mice
AK Kozlowska, K Kaur, P Topchyan, A Jewett
Front Biosci (Landmark Ed) 22 (2), 370-84, 2017
322017
ADCC against MICA/B is mediated against differentiated oral and pancreatic and not stem-like/poorly differentiated tumors by the NK cells; loss in cancer patients due to down …
K Kaur, T Safaie, MW Ko, Y Wang, A Jewett
Cancers 13 (2), 239, 2021
312021
Differential cytotoxicity but augmented IFN-γ secretion by NK cells after interaction with monocytes from humans, and those from wild type and myeloid specific COX-2 knockout mice
HC Tseng, A Arasteh, K Kaur, A Kozlowska, P Topchyan, A Jewett
Frontiers in immunology 6, 138779, 2015
302015
Suppression of gingival NK cells in precancerous and cancerous stages of pancreatic cancer in KC and BLT-humanized mice
K Kaur, HH Chang, J Cook, G Eibl, A Jewett
Frontiers in immunology 8, 300414, 2017
282017
Plasticity of myeloid cells during oral barrier wound healing and the development of bisphosphonate-related osteonecrosis of the jaw
Y Sun, K Kaur, K Kanayama, K Morinaga, S Park, A Hokugo, A Kozlowska, ...
Journal of Biological Chemistry 291 (39), 20602-20616, 2016
282016
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
K Kaur, MW Ko, N Ohanian, J Cook, A Jewett
Scientific Reports 10 (1), 20363, 2020
272020
Multiple defects of natural killer cells in cancer patients: Anarchy, dysregulated systemic immunity, and immunosuppression in metastatic cancer
A Jewett, J Kos, K Kaur, TL Turnsek, B Breznik, E Senjor, P Wong, ...
Critical Reviews™ in Immunology 40 (2), 2020
222020
The system can't perform the operation now. Try again later.
Articles 1–20